PT  - JOURNAL ARTICLE
AU  - Rizzo, Toni
ED  - Hall, Alistair
TI  - HTN Guidelines Favor Combination Therapy for HTN Management
DP  - 2014 Nov 01
TA  - MD Conference Express
PG  - 31--32
VI  - 14
IP  - 24
4099  - http://mdc.sagepub.com/content/14/24/31.short
4100  - http://mdc.sagepub.com/content/14/24/31.full
AB  - Blood pressure (BP) is a surrogate that is treated to prevent cardiovascular disease (CVD) and its consequences. However, outside of clinical trials, it is difficult to know how these outcomes are affected by antihypertensive therapy. Although clinical trials provide useful information, they do not give the full picture. Real-life practice is more complicated than clinical trials, but both need to be considered in managing hypertension (HTN). This article discusses the new international guidelines for the management of HTN were issued in Europe and the United States in 2013.